HOME >> MEDICINE >> NEWS
Different subgroups of alcoholics respond differently to serotonin-acting medication

  • Serotonin, a brain chemical, influences mood, emotions, sleep, appetite and temperature regulation.
  • Both short- and long-term alcohol consumption can damage serotonin functioning.
  • Selective serotonin reuptake inhibitors (SSRIs) help to maintain optimal levels of serotonin.
  • New findings indicate that Type A alcoholics respond better to an SSRI called sertraline (Zoloft) than do Type B alcoholics, both during treatment and for six months following treatment.

Alcoholism typologies are constructed according to a set of one or more variables such as age of onset, family history of alcoholism, and presence/absence of antisocial behavior. According to one such typology by Thomas Babor, Type A alcoholics are considered to be at lower risk/severity, Type B alcoholics at higher risk/severity. In previous research, the authors of a study in the July issue of Alcoholism: Clinical & Experimental Research showed that Type A alcoholics had a better treatment response to a selective serotonin reuptake inhibitor (SSRI) called sertraline than did Type B alcoholics. In their latest study, the authors have found that during the six months following treatment, Type A alcoholics maintained their gains, whereas Type B alcoholics who had taken sertraline did not.

"SSRIs are the most widely prescribed class of anti-depressants," said William Dundon, senior research investigator in the department of psychiatry at the University of Pennsylvania School of Medicine and first author of the study. "SSRIs work by affecting the level of serotonin in the brain and elsewhere in the body. In the brain, serotonin is thought to influence mood, emotions, sleep, appetite, and temperature regulation. When the level of serotonin is too low, SSRIs can prevent the re-use (or re-uptake) to help maintain an optimal level of this neurochemical. Since we know from research with animals and humans that the serotonin system is affected b
'"/>


14-Jul-2004


Page: 1 2 3 4

Related medicine news :

1. Different methods of adjuvant chemotherapy for colorectal cancer have similar outcomes
2. Different approaches required for monitoring suicide trends
3. Different cholesterol predicts heart risk too, new target for drugs?
4. Different parts of the brain handle fantasy and reality
5. Women May React To General Anesthesia Differently Than Men
6. Health And Wealth: Women Are DifferentOr Are They?
7. Medication helps alcoholics control drinking
8. Childhood abuse may predict social phobia, agoraphobia, and PTSD among adult alcoholics
9. Using naltrexone to treat alcoholics with a Mediterranean drinking pattern
10. Continued disruption of movement among alcoholics despite abstinence
11. Fine-tuning naltrexone treatment for alcoholics

Post Your Comments:
(Date:5/24/2013)... mutations central to the development of infantile myofibromatosis (IM)a ... and soft tissuemay provide new therapeutic targets, according to ... Sinai. The findings, published in the American Journal ... options for this debilitating disease, for which the only ... tumors. , IM is an inheritied disorder that develops ...
(Date:5/24/2013)... Mike Stoler believes that there is much to be ... York. That’s why he hosts “Building New York—New ... And that’s why he invited Robert Glazer, Chief Executive ... single specialty practice in the greater New York area, ... and sub-specialists service communities throughout New York and New ...
(Date:5/24/2013)... May 24, 2013 6Webs.com has educated ... out a home security monitoring provider. The ... 6Webs.com the useful resource consumers prefer for unbiased and ... their evaluations of the leading wireless home security system ... are rated on a number of key factors including ...
(Date:5/24/2013)... Bethesda, MD (PRWEB) May 24, 2013 ... to its growing base of clients. As a result ... reports a presence in 20 states around the ... providing medical transcription services to the healthcare industry ... nurses who use their years of clinical work ...
(Date:5/24/2013)... (HealthDay News) -- The number of U.S. patients ... time in an emergency room has increased by ... The study, conducted by researchers at the George ... Services in Washington, D.C., found that patients wait ... before being admitted to the ICU. The researchers ...
Breaking Medicine News(10 mins):Health News:Researchers identify first drug targets in childhood genetic tumor disorder 2Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 2Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 3Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 4Health News:2013 Best Wireless Security System Providers Reported by 6Webs.com 2Health News:The Dictation Source Signs Two National Hospital Chains 2Health News:The Dictation Source Signs Two National Hospital Chains 3Health News:Sharp Rise in ICU Admissions From U.S. Emergency Rooms 2
(Date:5/24/2013)... , May 24, 2013 ... administration for systemic delivery of therapeutic agents has been ... inhalation drug delivery showing significant promise. The crucial formulation ... a delivery device play a major role in the ... made in the development of new formulation techniques and ...
(Date:5/23/2013)... SAN DIEGO , May 23, 2013 Neurocrine ... Kevin Gorman , President and Chief Executive ... Bank 38 th Annual dbAccess Health Care Conference in ... Thursday, May 30 at 11:20 a.m. Eastern Time / 8:20 ... be accessed on the Company,s website at http://www.neurocrine.com . ...
(Date:5/23/2013)... Minn. , May 23, 2013  MGC Diagnostics ... a global medical technology company, today scheduled a conference ... quarter of fiscal year 2013, ended April 30, 2013. ... Thursday, May 30, 2013. The Company will report financial ... after the markets close on Thursday, May 30, 2013. ...
Breaking Medicine Technology:Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany 2MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 2
Cached News: